Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function
ClinicalTrials.gov study NCT04398680. IPD Sharing: YES. Countries: 3. Publications: 0.
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
ClinicalTrials.gov study NCT06179888. IPD Sharing: YES. Countries: 1. Publications: 0.
Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers
ClinicalTrials.gov study NCT02129569. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FT576 in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT05182073. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
ClinicalTrials.gov study NCT00389701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT07029776. IPD Sharing: NO. Countries: 1. Publications: 0.
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
ClinicalTrials.gov study NCT05974150. IPD Sharing: NO. Countries: 1. Publications: 0.
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04508790. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
ClinicalTrials.gov study NCT01122875. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06999031. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
ClinicalTrials.gov study NCT00007995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00821301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00021359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
ClinicalTrials.gov study NCT02572492. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT03464916. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
ClinicalTrials.gov study NCT07225738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
ClinicalTrials.gov study NCT04965155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide-Dexamethasone for Multiple Myeloma
ClinicalTrials.gov study NCT00038090. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma
ClinicalTrials.gov study NCT03641456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
ClinicalTrials.gov study NCT04162353. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.